The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome (Q38127598)

29 August 2017

title

The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome (English)

1 reference

29 August 2017

0 references

4

1 reference

29 August 2017

Graeme Meintjes

3

0 references

author name string

Rachel P J Lai

series ordinal

1

1 reference

29 August 2017

Justine K Nakiwala

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

European Journal of Immunology

29 August 2017

published in

1 reference

29 August 2017

volume

43

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

1995-2002

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Cutaneous Colesional Acquired Immunodeficiency Syndrome Associated Kaposi Sarcoma and Cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

TB or not TB: the role of immunodiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Management of patients with the immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Central nervous system disorders after starting antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Integration of antiretroviral therapy with tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Mediators of Innate and Adaptive Immune Responses Differentially Affect Immune Restoration Disease Associated withMycobacterium tuberculosisin HIV Patients Beginning Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Innate IL-17 and IL-22 responses to enteric bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

IL-17-producing γδ T cells and innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

IL-1, IL-18, and IL-33 families of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Mycobacterium-associated immune reconstitution disease: macrophages running wild?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Evidence that complement protein C1q interacts with C-reactive protein through its globular head region

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343632

7 January 2021

Identifiers

DOI

10.1002/EJI.201343632

1 reference

29 August 2017

1 reference